Evoke Pharma Overview
- Year Founded
-
2007
- Status
-
Acquired/Merged
- Employees
-
3
- Latest Deal Type
-
M&A
- Latest Deal Amount
-
$33.7M
Evoke Pharma General Information
Description
Evoke Pharma Inc is a specialty pharmaceutical company focused on the development and commercialization of drugs to treat gastrointestinal, or GI, disorders, and diseases. The company's product Gimoti is an investigational metoclopramide nasal spray for the relief of symptoms associated with acute and recurrent diabetic gastroparesis in women. Gimoti is a novel nasal spray formulation of metoclopramide designed to provide systemic delivery of the molecule through the nasal mucosa.
Contact Information
Website
www.evokepharma.com(Operating Subsidiary)
Corporate Office
- 420 Stevens Avenue
- Suite 230
- Solana Beach, CA 92075
- United States
Corporate Office
- 420 Stevens Avenue
- Suite 230
- Solana Beach, CA 92075
- United States
Evoke Pharma Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 9. Merger/Acquisition | 15-Dec-2025 | $33.7M | Completed | Generating Revenue | ||
| 8. 2PO | 09-Feb-2024 | Completed | Generating Revenue | |||
| 7. Secondary Transaction - Open Market | Completed | Generating Revenue | ||||
| 6. Secondary Transaction - Open Market | 06-Mar-2017 | Completed | Generating Revenue | |||
| 5. PIPE | 03-Aug-2016 | Completed | Generating Revenue | |||
| 4. Debt Refinancing | 28-May-2014 | Completed | Generating Revenue | |||
| 3. IPO | 25-Sep-2013 | Completed | Generating Revenue | |||
| 2. Early Stage VC | 29-Jun-2010 | $6M | $18.3M | Completed | Product Development | |
| 1. Early Stage VC (Series A) | 24-Feb-2009 | $12.3M | $12.3M | Completed | Product Development |
Evoke Pharma Comparisons
Industry
Financing
Details
Evoke Pharma Competitors (50)
One of Evoke Pharma’s 50 competitors is Ardelyx, a Formerly VC-backed company based in Waltham, MA.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Ardelyx | Formerly VC-backed | Waltham, MA | ||||
| Mirum Pharmaceuticals | Formerly VC-backed | Foster City, CA | ||||
| Alcresta Therapeutics | Private Equity-Backed | Waltham, MA | ||||
| Intracellular Therapies | Formerly VC-backed | Bedminster, NJ | ||||
| RedHill Biopharma | Formerly VC-backed | Raleigh, NC |
Evoke Pharma Patents
Evoke Pharma Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| US-20250302777-A1 | Methods for treating gastroparesis | Pending | 20-Dec-2022 | ||
| EP-4637739-A1 | Novel methods for treating gastroparesis | Pending | 20-Dec-2022 | ||
| WO-2024137805-A1 | Novel methods for treating gastroparesis | Inactive | 20-Dec-2022 | ||
| US-20250312297-A1 | Reduction of healthcare resource utilization by patients treated with intranasally-administered metoclopramide | Pending | 20-Dec-2022 | ||
| WO-2024137814-A1 | Reduction of healthcare resource utilization by patients treated with intranasally-administered metoclopramide | Inactive | 20-Dec-2022 | A61K31/166 |
Evoke Pharma Signals
Growth Rate
Growth
Size Multiple
Key Data Points
Similarweb Unique Visitors
Majestic Referring Domains
Evoke Pharma Former Investors (3)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Domain Associates | Venture Capital | Minority | ||
| Latterell Venture Partners | Venture Capital | Minority | ||
| Windamere Venture Partners | Venture Capital | Minority |
Evoke Pharma ESG
Risk Overview
Risk Rating
Updated March, 31, 2026
40.62 | Severe Risk
Risk Scale
A lower score indicates better sustainability
Negl
0-10
Low
10-20
Med
20-30
High
30-40
Severe
40+
Exposure
Exposure refers to the extent to which a company is exposed to different material ESG issues
Management
Management is related to actions taken to manage ESG issues
Peers Analysis
Peer performance insights compare the company’s ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements.
Global
Covered Companies
of 14,271
Rank
Percentile
Pharmaceuticals
Industry
of 908
Rank
Percentile
Pharmaceuticals
Subindustry
of 406
Rank
Percentile
Evoke Pharma FAQs
-
When was Evoke Pharma founded?
Evoke Pharma was founded in 2007.
-
Where is Evoke Pharma headquartered?
Evoke Pharma is headquartered in Solana Beach, CA.
-
What is the size of Evoke Pharma?
Evoke Pharma has 3 total employees.
-
What industry is Evoke Pharma in?
Evoke Pharma’s primary industry is Pharmaceuticals.
-
Is Evoke Pharma a private or public company?
Evoke Pharma is a Private company.
-
What is the current valuation of Evoke Pharma?
The current valuation of Evoke Pharma is .
-
What is Evoke Pharma’s current revenue?
The current revenue for Evoke Pharma is .
-
How much funding has Evoke Pharma raised over time?
Evoke Pharma has raised $66M.
-
Who are Evoke Pharma’s investors?
Domain Associates, Latterell Venture Partners, and Windamere Venture Partners have invested in Evoke Pharma.
-
Who are Evoke Pharma’s competitors?
Ardelyx, Mirum Pharmaceuticals, Alcresta Therapeutics, Intracellular Therapies, and RedHill Biopharma are some of the 50 competitors of Evoke Pharma.
-
When was Evoke Pharma acquired?
Evoke Pharma was acquired on 15-Dec-2025.
-
Who acquired Evoke Pharma?
Evoke Pharma was acquired by QOL Medical.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process
